Page 1 of 1

Enrollment completed in Phase III Copaxone MS trial

Posted: Thu Jun 02, 2011 7:15 am
by MSUK
Image


Teva Pharmaceutical Industries Ltd. today announced completion of patient enrollment for the GALA (Glatiramer Acetate Low-frequency Administration) trial. This international Phase III trial in patients with relapsing-remitting multiple sclerosis (RRMS), is designed to examine the efficacy, safe... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1767

Posted: Sat Jun 11, 2011 6:30 pm
by cathyb
Ugh, Mark Freedman.